FDA AI Strategy Faces Uncertainty After High-Level Turnover
High-level turnover at the FDA has introduced uncertainty about how quickly the agency's agency-wide AI strategy will move forward.
Digital Health / MedTech / BioTechSynthesized news with full source attribution.
High-level turnover at the FDA has introduced uncertainty about how quickly the agency's agency-wide AI strategy will move forward.
Digital Health / MedTech / BioTechAnthony Fauci, the nation's former top infectious disease expert, is scheduled to testify before Congress again tomorrow at the Senate homeland security committee.
Digital Health / MedTech / BioTechThe Centers for Medicare and Medicaid Services (CMS) announced that it will end subsidies for private Medicare drug plans, which could result in higher premiums for some seniors right before the midterm elections.
The US is heavily reliant on China for its pharmaceutical supply chain, a situation that has raised concerns about national security risks.
The Senate health panel delayed until next week a vote on Erica Schwartz to run the Centers for Disease Control and Prevention, after postponing a separate vote on Sean Kaufman for a key public health preparedness role.
Digital Health / MedTech / BioTechThe Senate health committee has delayed until next week a vote on Erica Schwartz to run the Centers for Disease Control and Prevention, after a lack of senators showed up.
The Centers for Medicare and Medicaid Services (CMS) has proposed a new rule to codify limits on Medicaid provider taxes, aimed at preventing states from guaranteeing providers will be refunded for their taxes.
Digital Health / MedTech / BioTechThe Trump administration has deferred over $1 billion in Medicaid payments to California and Minnesota due to suspected fraud and noncompliance.
Sens. Richard Blumenthal (D-Conn.) and Josh Hawley (R-Mo.) are calling on the nation's largest Medicare Advantage insurers to provide internal records and detailed information on their use of artificial intelligence to block rehabilitative care.
Digital Health / MedTech / BioTechA recent article by a prominent news outlet questioned the US's sovereignty in light of growing concerns over Kalshi, a mysterious phenomenon infecting the global news cycle.
TechbusinessMedicare is proposing a 33.4% cut in payments to hospitals for drugs acquired through the 340B drug discount program, which would dramatically reduce the discounts currently being offered.
Digital Health / MedTech / BioTechElevance Health has sued the U.S. government, alleging that federal efforts to recalculate its Medicare Advantage quality ratings didn't align with a recent court ruling, costing the health insurer $115 million.
Digital Health / MedTech / BioTech